Frequently Asked Questions

McLaren’s plan to relocate facilities in Lansing is based on its mission statement: “To be the best value in healthcare, as defined by quality outcomes and cost.” This list of frequently asked questions will help show why the move from outdated facilities at the Greenlawn and Pennsylvania campuses to one new facility alongside Collins Road north of Jolly Road – still in Lansing – fulfills that mission for McLaren Greater Lansing.

Why does McLaren want to do this?

Health care is changing and McLaren needs to consolidate and modernize its facilities to prepare to meet the future health care demands of the region. McLaren’s current Lansing facilities are nearing the end of their expected operational life and major improvements are necessary. Developing a new campus is the best way to ensure Mid-Michigan has a complete complement of the highest-quality health care services for generations to come.

Some of the facilities at the Greenlawn campus date to 1930; the first buildings at the Pennsylvania campus were built in 1959.

What does this mean for the McLaren and MSU relationship?

McLaren and Michigan State University both have, and will continue to have, strong relationships with a number of other partners throughout the state. McLaren and MSU’s partnership is focused on reshaping health care delivery, research, and education in the region for generations to come. The growing partnership will only benefit patients across Mid-Michigan and serve to advance the academic and research mission of MSU.

Michigan State University and McLaren have a long history of collaborating including:

  • As a teaching site of MSU’s two schools of medicine and nursing school, McLaren is a vital part of the training of our next generation of health care.
  • More than 165 MSU physicians are on the McLaren Greater Lansing medical staff.
  • McLaren Orthopedic Hospital is home to the MSU Center for Orthopedic Research.
  • MSU and McLaren researcher are partnering on 36 active protocols to better understand and treat breast, prostate and colon cancer, heart attacks and heart failure, strokes and more.

What is the relationship between McLaren Greater Lansing and Michigan State University today?

McLaren and Michigan State University have enjoyed a long and productive relationship on medical education, clinical care and research. As a teaching site of Michigan State University, McLaren Greater Lansing annually trains more than 150 residents, fellows and medical students from both the College of Human Medicine and College of Osteopathic Medicine.

McLaren and MSU researchers are already partnering on 36 active research protocols to better understand and treat breast cancer, prostate cancer, colon cancer, heart attacks, heart failure, COPD, strokes, and more. McLaren Orthopedic Hospital is also home to the MSU Center for Orthopedic Research.

Many attending and resident physicians serve in MSU faculty appointments, actively instructing and mentoring Michigan State University medical students. More than 165 MSU physicians are on the McLaren Greater Lansing medical staff and more than 50 MSU College of Nursing students trained at the hospital in 2016-2017.

Is the hospital becoming a part of Michigan State University and the MSU HealthTeam?

No, the hospital will remain owned and operated by McLaren. McLaren and Michigan State University and the MSU HealthTeam will remain independent entities but have agreed to collaborate on initiatives to deliver care, enhance medical education, and advance clinical research.

Where will the new health care campus be located?

The new health care campus will be developed at the MSU Foundation’s University Corporate Research Park, located between Collins Road and US 127.

When will it open?

The current timeline has the hospital opening in early 2022.

What are the major facility components of the project?

Plans are still coming together, but Lansing can expect these operations:

  • Acute Care Hospital. A state‐of‐the‐art 240-bed acute care hospital.
  • Karmanos Cancer Institute. A new cancer center will provide medical and radiological oncology treatments, as well as access for patients to clinical trials through Karmanos Cancer Institute, a national leader in cancer research and care and one of only two National Cancer Institute-designated comprehensive programs in the state.
  • Medical Services Building. The office building will provide space for the physicians necessary to support hospital operations in addition to other independent practices from the community. The office building will allow also for the consolidation of a number of services into a single location, improving efficiency.

Why not consolidate McLaren’s hospitals into one of the existing campuses?

We have done a comprehensive analysis of consolidating the Greenlawn and Pennsylvania campuses together at one of the existing site and is simply not feasible from a space, financial, and operational perspective. Neither campus has enough space to realistically combine both operations. Attempts to engineer less-than-ideal solutions on the existing sites were cost prohibitive, did not address fundamental operational challenges, and still left aging facilities to address.

What will happen to the current campuses?

McLaren is committed to repurposing our existing facilities for the betterment of the community. Between our future facility and the redevelopment of our two existing campuses, Lansing has three transformational opportunities to attract new services, businesses, and jobs to the region.

Even though we will not be moving to our new home until early 2022, repurposing efforts have already begun. In fact, McLaren and the Lansing Economic Area Partnership (LEAP) have already signed an agreement to partner to identify innovative organizations interested in repurposing McLaren’s existing facilities.

McLaren has served our community for more than a century and are committed to being good stewards of our current and future facilities in Lansing during the repurposing process.